1. The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines
   Annalisa Schirizzi et al, 2023, Frontiers in Oncology CrossRef
2. Paclitaxel resistance and nucleostemin upregulation in metastatic mouse breast cancer cells
   Naeemeh REZAPOUR et al, 2023, Minerva Biotechnology and Biomolecular Research CrossRef